Protein Sciences Responds to Emergent BioSolutio...(that theBLA has been accepted for substa...)

Date:7/10/2008

that the BLA has been accepted for substantive review by the FDA and PSC is today in the middle of its pre-approval inspection by the FDA and that PSC expects to hear shortly on its proposal for a very significant federal funding. EBS's attempt to destroy and discredit PSC and its senior management team is particularly reprehensible given that PSC's lead product, FluBlok, has the potential to save significant lives and may be a primary weapon in responding to any flu pandemic.

About PSC

PSC is a privately held biotechnology company that uses proprietary recombinant DNA technology to manufacture human and animal vaccines, therapeutics and diagnostics. Our lead product is a human seasonal flu vaccine - FluBlok(R). This product is currently in Phase III clinical trials with the FDA and our BLA for FluBlok has been accepted by the FDA for substantive review on an accelerated basis with an FDA action date of October 18, 2008. FluBlok may have important advantages over the existing flu vaccines and we are well situated to develop a vaccine if an influenza pandemic occurs. Our underlying technology is a viable alternative production platform to the egg-based production methods that currently dominate vaccine production and our 2007 revenues were in excess of $6,000,000, primarily from our GeneXpress and research antigen business.

'/>"/>

SOURCE Protein Sciences Corporation Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Enhanced Protein Tomography(TM) Method for Rapid Epitope Determination
2. Large-scale community protein annotation -- WikiProteins
3. The Protein Tomography(TM) Award Now Published on Sidecs Homepage
4. CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
5. Sidec Announces the First Protein Tomography(TM) Award at Sidecs Executive Forum at PEGS
6. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
7. Olympus FluoroPoint(TM) System Provides High-Sensitivity Single Molecule and Protein Interaction Analysis for Screening and Research
8. Marteks lifesDHA(TM) Now Available in Protein-free Powder
9. Sangamo BioSciences Announces Expansion of Research and License Agreement With Genentech for ZFP Technology for Protein Pharmaceutical Production
10. Immune system protein starves staph bacteria
11. Decision Biomarkers Launches System for Faster, Easier Quantification of Protein Biomarkers